home / stock / athe / athe quote
Last: | $ |
---|---|
Change Percent: | -5.61% |
Open: | $0.77 |
Close: | $0.7113 |
High: | $0.7763 |
Low: | $0.7011 |
Volume: | 35,028 |
Last Trade Date Time: | 02/12/2020 04:41:14 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.77 | $0.7113 | $0.7763 | $0.7011 | 35,028 | 02-12-2020 |
$ | $0.78 | $0.753546 | $0.805 | $0.71001 | 68,033 | 02-11-2020 |
$ | $0.90 | $0.805 | $0.90 | $0.7538 | 92,795 | 02-10-2020 |
$ | $0.74 | $0.7007 | $0.74 | $0.66 | 54,730 | 02-07-2020 |
$ | $0.79 | $0.77 | $0.79 | $0.7337 | 8,048 | 02-06-2020 |
$ | $0.77 | $0.79 | $0.79 | $0.77 | 9,983 | 02-05-2020 |
$ | $0.79 | $0.7501 | $0.8063 | $0.747089 | 10,033 | 02-04-2020 |
$ | $0.82 | $0.81 | $0.82 | $0.758 | 12,791 | 02-03-2020 |
$ | $0.78 | $0.79 | $0.85 | $0.7745 | 9,847 | 01-31-2020 |
$ | $0.79 | $0.7739 | $0.8125 | $0.7622 | 20,095 | 01-30-2020 |
$ | $0.81 | $0.7887 | $0.83 | $0.7739 | 8,129 | 01-29-2020 |
$ | $0.82 | $0.8015 | $0.8499 | $0.80 | 21,830 | 01-28-2020 |
$ | $0.771 | $0.81 | $0.82 | $0.771 | 28,475 | 01-27-2020 |
$ | $0.80 | $0.78 | $0.8001 | $0.7702 | 56,642 | 01-24-2020 |
$ | $0.79 | $0.76 | $0.804 | $0.76 | 45,769 | 01-23-2020 |
$ | $0.7611 | $0.785 | $0.79 | $0.76 | 22,467 | 01-22-2020 |
$ | $0.77 | $0.771981 | $0.79 | $0.7501 | 26,901 | 01-21-2020 |
$ | $0.725 | $0.76 | $0.78 | $0.725 | 29,392 | 01-20-2020 |
$ | $0.725 | $0.76 | $0.78 | $0.725 | 29,392 | 01-17-2020 |
$ | $0.80 | $0.741391 | $0.80 | $0.7107 | 237,211 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Alterity Therapeutics Limited Company Name:
ATHE Stock Symbol:
NYSE Market:
MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited ((ASX: ATH, NASDAQ:ATHE) ("Alterity" ...
MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative...
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson's Disease to be Presented at International Conference – – Baseline ...